Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus

  • STATUS
    Recruiting
  • End date
    Dec 31, 2024
  • participants needed
    110
  • sponsor
    Oregon Health and Science University
Updated on 9 May 2022
diabetes
fasting
capillary blood
blood glucose monitoring
continuous glucose monitoring

Summary

The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes

Details
Condition Gestational Diabetes
Treatment continuous glucose monitoring (CGM), Self-Capillary Blood Glucose Monitoring (SCBG)
Clinical Study IdentifierNCT04605497
SponsorOregon Health and Science University
Last Modified on9 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Age 18-55 years
Singleton pregnancy ≥20 weeks gestation
Diagnosed with GDM by either 1-step (IADPSG) or 2-Step (Carpenter-Coustan)
Compatible, validated phone and operating system to support Dexcom G6 CGM App (See Supplementary Table 1) or option to use receiver

Exclusion Criteria

Chronic immunosuppression
Concomitant disease or condition that may compromise patient safety or the ability to complete study tasks including and not limited to: severe mental illness or a diagnosed or suspected eating disorder
Known allergy to medical grade adhesives
Pre-gestational diabetes
Multifetal gestation
Current alcohol or illicit drug use
Simultaneous participation in another clinical study with investigational medicinal product(s) that might have an impact on the study objectives
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note